Magic mushroom therapy targets deep grief in small trial
NCT ID NCT06724289
First seen Mar 11, 2026 · Last updated Apr 29, 2026 · Updated 6 times
Summary
This early-phase study tests whether psilocybin-assisted therapy is feasible for people with prolonged grief disorder. Twelve adults aged 18-65 with severe grief symptoms will receive the treatment and be followed for 6 months. The main goals are to see if people join and stay in the study, and to measure changes in grief and trauma symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROLONGED GRIEF DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
University of Virginia
RECRUITINGCharlottesville, Virginia, 22903, United States
Conditions
Explore the condition pages connected to this study.